Loading…
Phages from Genus Bruynoghevirus and Phage Therapy: Pseudomonas Phage Delta Case
The applicability and safety of bacteriophage Delta as a potential anti- agent belonging to genus (family ) was characterised. Phage Delta belongs to the species , which has been described as a temperate, with sites at the end of the genome. The phage Delta possesses a genome of 45,970 bp that encod...
Saved in:
Published in: | Viruses 2021-09, Vol.13 (10), p.1965 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The applicability and safety of bacteriophage Delta as a potential anti-
agent belonging to genus
(family
) was characterised. Phage Delta belongs to the species
, which has been described as a temperate, with
sites at the end of the genome. The phage Delta possesses a genome of 45,970 bp that encodes tRNA for proline (Pro), aspartic acid (Asp) and asparagine (Asn) and does not encode any known protein involved in lysogeny formation or persistence. Analysis showed that phage Delta has 182 bp direct terminal repeats at the end of genome and lysogeny was confirmed, neither upon infection at low nor at high multiplicity of infection (MOI). The turbid plaques that appear on certain host lawns can result from bacteriophage insensitive mutants that occur with higher frequency (10
). In silico analysis showed that the genome of Delta phage does not encode any known bacterial toxin or virulence factor, determinants of antibiotic resistance and known human allergens. Based on the broad host range and high lytic activity against planktonic and biofilm cells, phage Delta represents a promising candidate for phage therapy. |
---|---|
ISSN: | 1999-4915 1999-4915 |
DOI: | 10.3390/v13101965 |